Regenxbio Inc (RGNX) support and resistance · rev $114.4M
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
This page maps Regenxbio Inc (RGNX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
RGNX currently screens at market cap $440.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RGNX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RGNX quote page for the session range and the stock page for the full model.
Not investment advice.